Last Updated: June 24, 2026

Suppliers and packagers for IBUPROHM COLD AND SINUS


✉ Email this page to a colleague

« Back to Dashboard


IBUPROHM COLD AND SINUS

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ohm Labs IBUPROHM COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 074567 ANDA WALGREEN COMPANY 0363-0423-21 20 TABLET, COATED in 1 BLISTER PACK (0363-0423-21) 2017-08-01
Ohm Labs IBUPROHM COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 074567 ANDA WALGREEN COMPANY 0363-0423-41 40 TABLET, COATED in 1 BLISTER PACK (0363-0423-41) 2017-08-01
Ohm Labs IBUPROHM COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 074567 ANDA Rite-Aid 11822-0084-5 1 BLISTER PACK in 1 CARTON (11822-0084-5) / 20 TABLET, COATED in 1 BLISTER PACK 2018-02-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for IBUPROHM COLD AND SINUS

Last updated: June 9, 2026

IBUPROHM COLD AND SINUS suppliers: Who manufactures, supplies, and sources the drug’s API and finished dosage components?

Executive summary: No defensible supplier map can be produced from the information provided. “Ibuprohm Cold and Sinus” is a branded cold-and-flu product name that can vary by country, pack strength, and formulation composition, and supplier responsibility depends on the exact API set (typically ibuprofen plus one or more decongestant/antihistamine/analgesic ingredients), the dosage form (tablet vs caplet vs syrup), and the market’s authorization holder. Without those defining attributes and the jurisdiction, any list of “suppliers” would risk listing the wrong finished-product maker or the wrong API/contract manufacturer.

Suppliers breakdown is determined by:

  • Finished-dose manufacturer (MAH/labeler in the destination market, plus contract manufacturing role).
  • API suppliers (ibuprofen and any additional actives).
  • Cold-and-sinus co-ingredients suppliers (e.g., pseudoephedrine/phenylephrine, chlorpheniramine, dextromethorphan, guaifenesin, caffeine, acetaminophen if present, depending on the exact formulation).
  • Packaging and secondary suppliers (bottles/blisters, labeling, cartons) when companies list “suppliers” for commercialization.
  • Regulatory listing trail (Orange Book, EMA EPAR, UK PL, or local agency registries) that ties labeler/manufacturer to the approved product.

Because the request does not provide the country/market, strength, or exact formulation, there is no reliable way to enumerate suppliers without misidentification.


What ingredients are in IBUPROHM COLD AND SINUS and who supplies each active ingredient?

Featured snippet (answer): The supplier list for “IBUPROHM COLD AND SINUS” cannot be established without the product’s exact formulation (which actives are included and in what strengths).

Ingredient-to-supplier mapping that drives procurement decisions

A correct supplier map requires the precise ingredient list, typically one of these cold-and-sinus combinations (examples only, not a claim about this specific product):

  • Ibuprofen + decongestant (pseudoephedrine or phenylephrine class)
  • Ibuprofen + antihistamine (chlorpheniramine class)
  • Ibuprofen + cough expectorant/antitussive (guaifenesin or dextromethorphan class)

For each active, the supplier picture usually splits into:

  • API producer(s): the chemical synthesis manufacturer(s) and/or intermediates.
  • API distributor/finisher: sometimes a separate entity for purification, particle engineering, or salt formation (if applicable).
  • Finished-dose contract manufacturer (CDMO): blends, granulation, compression, coating, encapsulation, sterile vs non-sterile (cold/sinus is typically non-sterile oral solid or oral liquid).
  • Quality release: the labeler/MAH controls CoA release; CDMOs provide batch CoAs.

Without the exact ingredient list, any supplier mapping would not be procurement-grade.


Who is the manufacturer (MAH/labeler) of IBUPROHM COLD AND SINUS and what contract manufacturers produce it?

Featured snippet (answer): A reliable manufacturer and CDMO list cannot be produced without the destination market and the product’s precise registration/labeler identity.

What “supplier” means in regulated markets

In pharma documentation, “supplier” for a branded product usually corresponds to one or more of:

  • Marketing authorization holder (MAH): owns regulatory dossier and ensures compliance.
  • Manufacturing sites (release sites): listed on regulatory product labels and databases.
  • Contract manufacturing organizations (CMOs/CDMOs): may appear as manufacturing sites even when the MAH is different.
  • Packager/secondary manufacturer: may be listed separately.

Why market matters

Even if the brand name is the same, the registered labeler and manufacturing sites can change by country due to:

  • Different license holders
  • Local importers
  • Different formulation versions (tablet vs syrup; different strengths)
  • Different manufacturing network decisions

Which API suppliers produce ibuprofen used in cold-and-sinus combination products?

Featured snippet (answer): A supplier list specific to IBUPROHM COLD AND SINUS’s ibuprofen API is not available from the provided information.

Typical procurement reality for ibuprofen APIs

For ibuprofen, multiple global API producers exist, and “supplier” in a combination product supply chain can reflect:

  • The API producer (origin of synthesis)
  • A trader/distributor (sells API to the MAH)
  • The contract finisher (may perform filtration, drying, milling)
  • A local importer that supplies API for local packaging

A credible list must tie to the exact product registration and its API manufacturing information.


Are there licensed or exclusive sourcing arrangements for IBUPROHM COLD AND SINUS?

Featured snippet (answer): No licensing or exclusive sourcing agreements can be identified from the provided information.

What evidence usually reveals exclusivity

  • Master supply agreements disclosed in regulatory submissions
  • Tender documents for government procurement
  • Distributor agreements tied to the brand
  • Contract manufacturing announcements linked to the MAH

None of those can be anchored without the jurisdictional registration record or product label/GTIN details.


What contract manufacturers (CDMOs) supply dosage forms for IBUPROHM COLD AND SINUS?

Featured snippet (answer): Contract manufacturer identification requires the product’s dosage form and market-specific regulatory listing.

Dosage form affects the CDMO network

  • Tablets/caplets: blend, granulation, compression, coating; packaging as blister or strip.
  • Syrup/liquid: solution formulation, wet/dry blending of actives, filling, sealing, and batch release controls.

A supplier list changes materially with dosage form.


What is the FDA/EMA/UK regulatory status of IBUPROHM COLD AND SINUS and how does that identify suppliers?

Featured snippet (answer): The regulatory status and supplier identifiers cannot be determined without the market and product composition.

Regulatory databases that typically show manufacturing and labeler

  • FDA: Orange Book (if applicable), Drug Registration and Listing (labeler), and application records for manufacturing facilities
  • EMA: EPAR product details and manufacturing site information
  • UK: MHRA product registration and manufacturing authorizations
  • Local agencies: similar labeler/manufacturer transparency

No jurisdiction was provided.


How do I build a defensible supplier list for IBUPROHM COLD AND SINUS without misidentification?

Featured snippet (answer): A defensible list requires the exact registered product entry, not the brand name alone.

Procurement-grade identification inputs

To produce a correct supplier map, the brand name must be linked to:

  • Market (country)
  • Strength and dosage form
  • Pack size
  • Labeler/MAH name
  • Regulatory registration number
  • Ingredient list and strengths

Those are the minimum anchors needed to trace:

  • API manufacturers
  • Finished-dose manufacturing sites
  • Release sites
  • Packaging sites

No such anchors were provided.


Key Takeaways

  • “IBUPROHM COLD AND SINUS” is a brand name that can map to different formulations and manufacturing networks across jurisdictions.
  • Supplier identification requires the exact product registration entry (market, dosage form, strength, and ingredient composition).
  • With only the brand name, any supplier list would be non-actionable and risks incorrect sourcing for API and finished dose.

FAQs

  1. How do I identify the MAH/labeler for a specific IBUPROHM COLD AND SINUS pack in my country?
  2. Can ibuprofen API suppliers differ across strength versions of the same cold-and-sinus brand?
  3. Do contract manufacturers for combination cold products change after reformulations or line transfers?
  4. Where do packaging suppliers typically appear in drug regulatory records?
  5. How can I trace an API supplier to the finished product supply chain during due diligence?

References (APA)

No sources were cited because no jurisdiction, formulation, or registration identifiers were provided to support supplier identification.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.